Growth Metrics

Enovis (ENOV) Cash from Investing Activities (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Enovis 1.25 Bn 1.22 Bn 365.49 Mn

Historic Data

Download Data 🔒
DateValue
Apr 3, 2026 -308.71%
Dec 31, 2025 76.83%
Oct 3, 2025 -12.57%
Jul 4, 2025 17.71%
Apr 4, 2025 -4.55%
Dec 31, 2024 0.92%
Sep 27, 2024 -41.37%
Jun 28, 2024 94.82%
Mar 29, 2024 -1,243.80%
Dec 31, 2023 -247.06%
Sep 29, 2023 87.00%
Jun 30, 2023 -282.73%
Mar 31, 2023 7.26%
Dec 31, 2022 37.31%
Sep 30, 2022 -31.40%
Jul 1, 2022 -27.98%
Apr 1, 2022 -31.08%
Dec 31, 2021 -24.50%
Oct 1, 2021 85.05%
Jul 2, 2021 -12.56%
Apr 2, 2021 -40.75%
Dec 31, 2020 -191.94%
Oct 2, 2020 -98.14%
Jul 3, 2020 57.80%
Apr 3, 2020 -102.33%
Dec 31, 2019 7,650.13%
Sep 27, 2019 43.79%
Jun 28, 2019 98.81%
Mar 29, 2019 -1,343.80%
Dec 31, 2018 -385.61%
Sep 28, 2018 -129.94%
Jun 29, 2018 379.37%
Mar 30, 2018 -132.29%
Dec 31, 2017 1,088.94%
Sep 29, 2017 65.40%
Jun 30, 2017 -317.96%
Mar 31, 2017 70.96%
Dec 31, 2016 -149.31%
Sep 30, 2016 -60.01%
Jul 1, 2016 34.32%
Apr 1, 2016 48.23%
Dec 31, 2015 85.05%
Sep 25, 2015 -2,679.25%
Jun 26, 2015 35.87%
Mar 27, 2015 49.93%
Dec 31, 2014 -32.37%
Sep 26, 2014 98.28%
Jun 27, 2014 -7,669.52%
Mar 28, 2014 96.93%
Dec 31, 2013 -1,315.23%
Sep 27, 2013 -64.10%
Jun 28, 2013 1.71%
Mar 29, 2013 90.56%
Dec 31, 2012 -296.95%
Sep 28, 2012 -59.81%
Jun 29, 2012 98.21%
Mar 30, 2012 -4,426.31%
Dec 31, 2011 -751.47%
Sep 30, 2011 -29.90%
Jul 1, 2011 86.81%
Apr 1, 2011 -515.38%
Dec 31, 2010 86.66%